News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>G Sachs Keeps Neutral on WUXI BIO (02269.HK) with TP HKD25.6
Goldman Sachs published a research report on WUXI BIO (02269.HK), which issued a positive profit alert, expecting interim revenue to grow approximately 16% YoY, aligning with the f...
Reset
Send
The window will close in 5 seconds
<Research>G Sachs Keeps Neutral on WUXI BIO (02269.HK) with TP HKD25.6
Close
Recommend
8
Positive
15
Negative
19
 
SHORT SELL
 
STOCK INFO

Goldman Sachs published a research report on WUXI BIO (02269.HK)  -0.850 (-2.640%)    Short selling $297.81M; Ratio 19.357%   , which issued a positive profit alert, expecting interim revenue to grow approximately 16% YoY, aligning with the full-year growth guidance of 12-15%. Net profit was expected to hike by 56% YoY, slightly topping forecast.

Goldman Sachs maintained a Neutral rating on WUXI BIO and a target price of HKD25.6, expecting investors to focus on the growth momentum of new orders outside of ADC/XDC, progress of late-stage and commercialization projects, and the expansion pace of overseas capacity.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-08-01 16:25.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.